Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify the natural history of knee osteoarthritis, announces that it has been authorized by Health ...

North Korea sent around 3,000 additional troops to Russia in January and February in continued support for Russian President Vladimir Putin's war on Ukraine, South Korea's military said Thursday in ...

Celltrion, Inc., today announced that STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) has been added to ...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to ...

South Korean biotech firms are targeting the $26 billion biosimilar market opening up as patents expire on more than 10 ...

Celltrion announced the commercial launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen’s STELARA® (ustekinumab), in the United States. As we previously reported, the biosimilar was ...

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Alteogen has seen a rise of over 8% after signing a licensing contract that could yield more than 2 trillion won depending on the individual product's progress. At 2:52 p.m. on the 17th, Alteogen was ...

As Remdantry uses the same Drug Identification Number (DIN) as Inflectra ®, the formulation, indications and dosages of Remdantry will remain the same as that of Inflectra, which was originally ...

Photo of a young man with a laughing gas mask The FDA warns that misuse of nitrous oxide is causing serious injuries Flavored nitrous products are being sold in colorful packaging at gas stations ...

WHITEHORSE, YT, March 13, 2025 /CNW/ - In Canada, one in 12 people live with a rare disease and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care ...